Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
548.25B | 575.66B | 555.96B | 479.08B | 389.71B | 410.96B | Gross Profit |
198.67B | 209.10B | 192.01B | 168.65B | 116.37B | 124.50B | EBIT |
54.31B | 66.22B | 68.30B | 52.86B | 27.18B | 24.20B | EBITDA |
76.44B | 86.55B | 83.17B | 70.19B | 42.14B | 40.22B | Net Income Common Stockholders |
44.31B | 50.69B | 51.78B | 38.35B | 18.93B | 15.57B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
16.43B | 44.69B | 46.74B | 57.23B | 52.91B | 41.96B | Total Assets |
241.65B | 702.34B | 653.13B | 559.04B | 487.43B | 450.13B | Total Debt |
42.23B | 95.90B | 99.56B | 68.04B | 76.54B | 81.58B | Net Debt |
25.80B | 55.62B | 57.29B | 12.89B | 25.59B | 41.27B | Total Liabilities |
148.36B | 294.32B | 298.06B | 260.94B | 237.87B | 218.96B | Stockholders Equity |
88.46B | 399.34B | 347.50B | 291.23B | 246.27B | 228.36B |
Cash Flow | Free Cash Flow | ||||
20.30B | 23.59B | -24.14B | 25.01B | 30.99B | -845.00M | Operating Cash Flow |
59.90B | 54.62B | -2.21B | 49.23B | 39.60B | 21.48B | Investing Cash Flow |
-28.59B | -29.35B | -19.69B | -24.16B | -9.60B | -20.64B | Financing Cash Flow |
-18.72B | -29.42B | 7.20B | -22.48B | -20.28B | 491.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $108.85B | 29.25 | 20.23% | 1.39% | 7.25% | 18.36% | |
74 Outperform | $127.72B | 22.81 | 33.10% | 2.23% | 5.05% | 2.73% | |
72 Outperform | $56.98B | 24.03 | 9.66% | 2.09% | 10.29% | 22.72% | |
68 Neutral | $25.94B | 28.54 | 26.22% | 2.23% | -11.28% | -23.69% | |
68 Neutral | $29.57B | 35.63 | 8.40% | 0.11% | 5.22% | 8.01% | |
62 Neutral | $7.70B | 13.14 | 3.53% | 3.32% | 3.90% | -14.25% | |
61 Neutral | $5.09B | 13.58 | 13.62% | 1.49% | -11.88% | 15.55% |